repair face base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

In cosmetic gels, emulsions, and washes, glycerin functions as a polyol humectant; its listed level is a guide.

3. Typical use levels (formulation guide)

• 3–8% is listed for gels and serums.
• For creams, the recorded level is 2–5% for the formula.
• 2–4% is listed for rinse-off in this reference.

Incorporate Glycerin in the water phase without a separate melt step.

4. Regulatory sources & global compliance

• Database information on Glycerin does not replace review of the supplied grade and finished product under market rules.
• For cosmetics placed on the EU market, Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Glycerin before the finished product is marketed.
• Review the documentation for the actual Glycerin grade and the filing requirements for the target market.

5. Safety & risk assessment

This entry provides guidance for cosmetic use only; no drug approval or OTC-monograph status follows from this guide and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; review airless or pump options if oxidation presents a concern; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The cosmetic role of Glycerin is presented as humectant function.

• This product entry provides no basis for a drug effect, a clinical cure, or certification status not established for the SKU.
• This guide to Glycerin does not substantiate skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

A plant-derived grade of squalane is specified here. It is a stable hydrocarbon emollient and is distinct from mineral oil.

3. Typical use levels (formulation guide)

• The gel-creams use-level reference is 2–6% as a formulation guide.
• The level shown for dry oils is 10–30% in this reference.
• The balms use-level reference is 5–15% as a formulation guide.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Regulatory sources & global compliance

• If CosIng lists Squalane, that listing remains ingredient information; check rules for the intended market and use.
• For an EU-market product, Regulation (EC) No 1223/2009 requires the final cosmetic with Squalane to undergo a safety assessment as a finished-product assessment.
• Check the supplier's technical information for the Squalane grade and confirm the relevant market filing list.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it does not authorize a drug or OTC product and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; review airless or pump options if oxidation presents a concern; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Squalane emphasizes a light-emollient role.

• The ingredient guidance does not establish therapeutic effects, curative outcomes, or unsupported certification statements.
• The information about Squalane should not be used to substantiate whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

Shea butter is included as a triglyceride butter for cushioning creams, balms, and hair creams; unrefined color and fragrance are not assumed.

3. Typical use levels (formulation guide)

• For creams, the recorded level is 2–8% in this reference.
• The formulation record indicates 10–25% for balms and butters in this reference.

Melt Butyrospermum Parkii Butter into the oil phase, then cool under shear to help prevent graininess.

4. Regulatory sources & global compliance

• An entry for Butyrospermum Parkii Butter in CosIng is not authorization for a material grade or completed cosmetic; review local requirements.
• EU market placement under Regulation (EC) No 1223/2009 requires the completed product containing Butyrospermum Parkii Butter to receive its own safety assessment as a finished-product assessment.
• Match the selected Butyrospermum Parkii Butter material to its supplier TDS and check the filing list for the market of sale.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; this reference is not approval for drug use or OTC marketing and the finished formula still needs patch and stability testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; for oxidation-sensitive formulas, consider an airless or pump pack; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• For cosmetic use, this entry records Butyrospermum Parkii Butter in a direction centered on shea cushion.

• The development record is not evidence of claims of drug action or cure, or a product certification outside the supporting records.
• The information about Butyrospermum Parkii Butter is not evidence for skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.